ARTICLE | Company News
Boston University, RCT deal
February 5, 2001 8:00 AM UTC
The university and RCT BioVentures NE, a 1999 spinout of Research Corp. Technologies formed Sedecim Therapeutics Inc. (Concord, Mass.) to develop IL-16 to treat HIV. Sedecim has an exclusive license t...